Old Web
English
Sign In
Acemap
>
authorDetail
>
Samar Krhili
Samar Krhili
Curie Institute
Radiation therapy
Medicine
Cisplatin
locally advanced
Hafnium oxide
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I study of functionalized hafnium oxide nanoparticles (NBTXR3) activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients.
2021
Journal of Clinical Oncology
Christophe Le Tourneau
Valentin Calugaru
Zoltán Takácsi-Nagy
Xavier Liem
Zsuzsanna Papai
Jacek Fijuth
Victor Moreno
Jordi Giralt
Sébastien Salas
Gilles Poissonnet
Emiliano Calvo
Bernard Doger
Olivier Choussy
Xavier Mirabel
Samar Krhili
K. Bernois
Nicolas Fakhry
Stéphanie Wong Hee Kam
Edith Borcoman
Caroline Hoffmann
Show All
Source
Cite
Save
Citations (0)
Phase I Study of Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients.
2021
International Journal of Radiation Oncology Biology Physics
C. Le Tourneau
Valentin Calugaru
Z. Takácsi Nagy
X. Liem
Zsuzsanna Papai
Jacek Fijuth
V. Moreno Garcia
I.Brana Garcia
Sébastien Salas
Gilles Poissonnet
Emilio Calvo
Bernard Doger
Olivier Choussy
Xavier Mirabel
Samar Krhili
K. Bernois
Nicolas Fakhry
S. Wong Hee Kam
Edith Borcoman
Caroline Hoffmann
Show All
Source
Cite
Save
Citations (0)
Phase I trial of hafnium oxide nanoparticles activated by radiotherapy in cisplatin-ineligible locally advanced HNSCC patients.
2020
Journal of Clinical Oncology
Christophe Le Tourneau
Valentin Calugaru
Edith Borcoman
Victor Moreno
Emiliano Calvo
X. Liem
Sébastien Salas
Bernard Doger
Olivier Choussy
Maria Lesnik
Xavier Mirabel
Nathalie Badois
Samar Krhili
Josefin Blomkvist
Nicolas Fakhry
Stéphanie Wong Hee Kam
Caroline Hoffmann
Show All
Source
Cite
Save
Citations (0)
1